Training Study to Evaluate the Benefit of Exercise for Patients With Chronic Heart Failure

NCT ID: NCT00934609

Last Updated: 2009-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study investigates the safety and effectiveness of a 12 week endurance training program for patients with chronic heart failure

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dilated Cardiomyopathy Chronic Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Training

12 weeks of endurance training on the cycle ergometer under supervision on a physician

Group Type EXPERIMENTAL

Endurance training

Intervention Type BEHAVIORAL

45 min ergometer cycling at the ventilatory anaerobic threshold 4 times per week for 12 weeks

Control

Control condition

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endurance training

45 min ergometer cycling at the ventilatory anaerobic threshold 4 times per week for 12 weeks

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* chronic heart failure NYHA stage 2 and 3

Exclusion Criteria

* Valvular disease
* recent decompensation
* Other complaints that might interfere with ergometer exercise
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The German Heart Foundation

OTHER

Sponsor Role collaborator

Universität des Saarlandes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Institute of Sports- and Preventive Medicine, Saarland University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Sports- and Preventive Medicine, Saarland University

Saarbrücken, Saarland, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2000-01SaarlandU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The SMARTEX Heart Failure Study
NCT00917046 COMPLETED NA